Metabolic syndrome (MetS) is a cluster of metabolic diseases that are linked to atherosclerotic cardiovascular disease. MetS have also been linked to increased nephrolithiasis. However, limited research has been conducted on MetS and its impact on stone specific health-related quality of life (HRQOL). This study aims to examine the hypothesis that the presence of MetS […]
Our study demonstrated that pelvic visceral fat (PVF) and working space (WS) in the pelvic cavity are factors that significantly affect operative time in robot-assisted radical prostatectomy (RARP). Diverse space volumes were measured using the Synapse Vincent® (FUJIFILM, Tokyo) 3D image analysis software. This technology allows calculation of the volume of any space using magnetic […]
In this issue Non-muscle Invasive Bladder Cancer: Overcoming Diagnostic and Therapeutic Challenges Update on Low-Grade Upper Tract Urothelial Carcinoma Spotlight: ASCO 2020 Virtual Education Program, EAU 2020 Virtual Annual Meeting, and SUO – AUA 2020 Summer Webcast {optin-asset[id:69,label:Download PDF,linkClass:button download]}
EAU Patient Information (EAU PI), the patient initiative of the European Association of Urology (EAU), is pleased to introduce its new Chairman: Mr. Eamonn T. Rogers (pictured right). Recently, Mr. Rogers (Galway, IE) took over as Chairman from Dr. Mark Behrendt (Amsterdam, NL) who chaired EAU PI from June 2019 to September 2020 and headed […]
Atlanta, Georgia (UroToday.com) Dr. Edward Schaeffer of Northwestern University in Chicago, Illinois, presented on “Prostate Cancer Genetics: Heritable Causes that Impact Treatment” at the 2020 Prostate Cancer Academy.
Pancreatic duct stones are direct sequelae of chronic pancreatitis (CP) and can occur in ∼50% of patients. Selection of the appropriate treatment method for pancreatic duct stones depends on location, size and number of stones.
Despite the fact that the majority of gallstones formed in the gallbladder are mainly composed of cholesterol, as they are formed from cholesterol-supersaturated bile, and hypercholesterolemia is a common metabolic disorder, which is closely related to cardiac, hepatic, renal and other oxidative damage inflammation and necrosis, there is still no consensus regarding the contribution of […]
While urolithiasis is epidemiologically and mechanistically linked to gout, urologic stone disease is not actively investigated in gout patients. Prevalence estimates on the coexistence of urolithiasis in gout have mostly relied on clinical history alone.
In most cases, it is not difficult to differentiate common bile duct (CBD) stone from Ascaris infection because they are different disease entities and have different imaging findings. The two diseases usually demonstrate unique characteristic findings on computed tomography or magnetic resonance cholangiopancreatography.
Although nephrolithiasis is a more common disease in men rather than women, several studies over the last decades show that the male to female ratio 3:1 is narrowing. These finding may be associated to modified risk factors for stone formation between females and males.
